Información del producto
- [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12R*,13R*)]-3-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetr ahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]pentadecanoic
Seco-erythromycin is a semisynthetic antibiotic that belongs to the group of macrolides. It is used in life science research and as a medicine for infections caused by bacteria, viruses, and parasites. Seco-erythromycin has been shown to have antibacterial, antifungal, antiviral, antiparasitic, and antimicrobial activity against microorganisms. It was originally isolated from Streptomyces erythreus. The compound was synthesized in 1955 by Dr. Paul Janssen in his laboratory at Janssen Pharmaceutica NV (now Johnson & Johnson).
Propiedades químicas
Consulta técnica sobre: 3D-AS16853 seco erythromycin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.